When a regulator loses its way
This article was originally published in RAJ Devices
The US Food and Drug Administration has conceded that its device approval processes need to be better protected against outside pressures after admitting to failings in the way its devices centre reviewed ReGen Biologics’s Menaflex device.
You may also be interested in...
Nano-X Imaging is on a mission to disrupt the market for X-ray imaging equipment by offering a low-cost medical imaging service to untapped markets through a network of equipment dotted around the world. However, some shareholders are claiming the company mislead investors.
The test measures the relative level of antibodies, which could aid vaccine rollout.
The market for devices to treat chronic obstructive pulmonary disease (COPD) is set to grow by 5.0% annually in the next three years, with the US market expanding by 5.7% per year, according to the Meddevicetracker Dashboard.